Wellington Management Group
MLYS icon

Wellington Management Group’s Mineralys Therapeutics MLYS Stock Holding History

Wellington Management Group’s Portfolio MLYS Stock Details MLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$91M Buy
3,359,068
+2,574,801
+328% +$75.5M 0.02% 568
2025
Q4 		$28.5M Buy
784,267
+822
+0.1% +$33K 0.01% 911
2025
Q3 		$29.7M Buy
783,445
+667,997
+579% +$14.4M 0.01% 883
2025
Q2 		$1.56M Sell
115,448
-6,109
-5% -$88.5K ﹤0.01% 1630
2025
Q1 		$1.93M Buy
121,557
+30,028
+33% +$345K ﹤0.01% 1568
2024
Q4 		$1.13M Buy
91,529
+27,531
+43% +$360K ﹤0.01% 1695
2024
Q3 		$775K Buy
+63,998
New +$775K ﹤0.01% 1755
2023
Q2 		– Sell
-24,224
Closed -$379K – 1934
2023
Q1 		$379K Buy
+24,224
New +$408K ﹤0.01% 1881

Other funds holding MLYS

CP
Catalys Pacific Tokyo, Japan $231M AUM 83.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Wellington Management Group's MLYS Position: Q1 2026 in Review

Wellington Management Group increased its Mineralys Therapeutics (MLYS) stake by 328% in Q1 2026, buying an estimated $75.5M and bringing the position to 3,359,068 shares worth $91M. The position accounts for 0.02% of the portfolio, ranked #568.

Wellington Management Group first reported a position in MLYS in Q1 2023 and has held it in 8 quarters since. 214 funds tracked by Wall St. Rank hold MLYS as of Q1 2026.

  • Wellington Management Group held 3,359,068 shares of Mineralys Therapeutics worth $91M as of Q1 2026.
  • Wellington Management Group bought 2,574,801 Mineralys Therapeutics shares in Q1 2026, an estimated $75.5M.
  • Mineralys Therapeutics made up 0.02% of Wellington Management Group's portfolio in Q1 2026, its #568 holding.
  • Wellington Management Group first reported a position in Mineralys Therapeutics in Q1 2023 and has held it in 8 quarters since.
  • 214 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.